In the tau P301S-transgenic mice of a tauopathy model, the ablation of the LGMN gene significantly suppressed the cleavage and hyperphosphorylation of tau, prevented a reduction in synapses and dendritic spines, and ameliorated cognitive impairment and memory loss [41]. This evidence concerns the gene MAPT and tauopathy.